|
|
|
|
| LEADER |
01352cam a2200409 4500 |
| 001 |
PPN020262612 |
| 005 |
20240327055500.0 |
| 010 |
|
|
|a 0-8247-7765-4
|
| 020 |
|
|
|a US
|b 8713631 //r89
|
| 035 |
|
|
|a ocm15791506
|
| 035 |
|
|
|z ocm17649289
|
| 100 |
|
|
|a 19870514d1987 k y0frey0103 ba
|
| 101 |
0 |
|
|a eng
|
| 102 |
|
|
|a US
|
| 105 |
|
|
|a a z 001yy
|
| 106 |
|
|
|a r
|
| 200 |
0 |
|
|a Commercial production of monoclonal antibodies
|b Texte imprimé
|e a guide for scale-up
|f ed. by Sally S. Seaver
|
| 210 |
|
|
|a New York
|c M. Dekker
|d 1987
|
| 215 |
|
|
|a 1 vol. (XVII-327 p.)
|c ill.
|d 24 cm
|
| 225 |
2 |
|
|a Bioprocess technology
|x 0888-7470
|v 2
|
| 320 |
|
|
|a Bibliogr. Index
|
| 410 |
|
| |
|0 013548476
|t Bioprocess technology
|x 0888-7470
|v 2
|
| 606 |
|
|
|3 PPN040671178
|a Biotechnologie
|2 fmesh
|
| 606 |
|
|
|3 PPN040663426
|a Anticorps monoclonaux
|2 fmesh
|
| 606 |
|
|
|3 PPN027618773
|a Microbiologie industrielle
|2 rameau
|
| 606 |
|
|
|3 PPN027880966
|a Anticorps monoclonaux
|2 rameau
|
| 676 |
|
|
|a 615/.37
|v 19
|
| 680 |
|
|
|a TP248.M65
|b C66 1987
|
| 686 |
|
|
|a W1
|b BI88U v.2 1987
|2 usnlm
|
| 686 |
|
|
|a TP248.2.B463
|b v.2
|2 usunal
|
| 702 |
|
1 |
|3 PPN122786637
|a Seaver
|b Sally S.
|4 340
|
| 801 |
|
3 |
|a FR
|b Abes
|c 20080401
|g AFNOR
|
| 801 |
|
1 |
|a US
|b OCLC
|g AACR2
|
| 801 |
|
2 |
|a FR
|b AUROC
|g AFNOR
|
| 930 |
|
|
|5 441092101:33196323X
|b 441092101
|a QW 575 SEA
|j u
|
| 979 |
|
|
|a SAN
|
| 998 |
|
|
|a 302513
|
Nantilus
